(1 - 13 from 13
)
LabCorp Hires Jonathan Zung as Group President of Clinical ...
ir.labcorp.com
BURLINGTON, N.C.--(BUSINESS WIRE)--Apr. 11, Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH) today announced that Jonathan Zung, Ph.D., has been named group president, Clinical Development & Commercialization Services for Covance Drug Development, effective April 5, Zung joins LabCorp from UCB, where he was vice president and head of Global Clinical Sciences …
sorted by relevance / date